rs1617640 A>C是慢性阻塞性肺病的保护因素:一个病例控制研究
Yunchao Wang1, Zhi Li2, Xiaoyi Zhang1
1Institute of Basic Medicine, Institute of Public Health, Gansu University of Chinese Medicine, 730000 Lanzhou, Gansu, China.
Frontiers in bioscience (Landmark edition)
|October 5, 2023
概括
红素 (EPO) rs1617640 A>C基因变异与较低的慢性阻塞性肺病 (COPD) 风险和改善的肺功能有关,在中国南部的人口中. 这种遗传标记可能有助于预测COPD风险与环境因素一起.
科学领域:
- 遗传学 是一个遗传学.
- 肺部医学 肺部医学
- 环境健康 环境健康
背景情况:
- 慢性阻塞性肺病 (COPD) 的发展受到遗传和环境因素的影响.
- 红素 (EPO) 在氧气恒温中起作用,而低氧在COPD中很常见.
- 以前的研究表明EPO参与了COPD,但机制仍然不清楚.
研究的目的:
- 调查EPO基因多态化与中国南部人口中COPD易感性之间的关联.
- 评估EPO多态对肺功能 (FEV1和FVC) 的影响.
- 探索EPO多态的潜力,作为COPD风险预测的遗传标记.
主要方法:
- 一项涉及1095名COPD患者和广东省1144名健康对照者的病例控制研究.
- 对于EPO多态的基因定型 (rs1617640 A>C,rs507392 A>G,rs564449 G>T).
- 来自甘省的872名参与者的肺功能验证,分析与EPO多态性和环境因素的关联.
主要成果:
- EPO rs1617640 C等位基因与COPD易受性降低显著相关 (OR=0.805对于AC与AA).
- 没有发现rs507392和rs564449多形态与COPD易感性的关联.
- rs1617640 C等位基因与更高的FEV1和FVC相关,肺功能随C等位基因数增加而增加.
结论:
- EPO rs1617640 A>C多态性是中国南部人群中COPD易感性的重要因素.
- rs1617640的C等位基因与更好的肺功能有关,这表明它具有保护作用.
- EPO rs1617640 A>C可以作为一个有价值的遗传标记,结合环境因素,预测10年COPD风险.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Pathogenesis and Clinical Features
317
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
317
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K


